Status:
UNKNOWN
Analysis of the Osteogenic Potential of Multipotent Cells From Different Anatomical Regions
Lead Sponsor:
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Conditions:
Complications; Implant, Orthopedic
Eligibility:
All Genders
50-80 years
Brief Summary
The aim of hip replacement surgery is to re-establish the physiological hip function and to obtain a stable fixation between the prosthetic components and the native bone. Commonly, the fixation is ob...
Eligibility Criteria
Inclusion
- Patients undergoing hip replacement and affected by:
- hip osteoarthritis
- mild developmental dysplasia of the hip
- 18 ≤ Body Mass Index (BMI) ≤ 30 kg/m2
Exclusion
- Rheumatoid arthritis
- Patients under pharmacological treatment for bone metabolic disorders
- Patient affected by metabolic disorders, which may affect bone metabolism
- Presence of bone metastases
- Presence of bone infections
- Patients undergoing hip revision surgeries
- Obesity (BMI ≥30kg/m2)
Key Trial Info
Start Date :
January 10 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 14 2020
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT03369457
Start Date
January 10 2018
End Date
June 14 2020
Last Update
April 16 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS Istituto Ortopedico Galeazz
Milan, Italy, 20161